‹ All stocks
TuHURA Biosciences
HURA · NASDAQ · Healthcare
$1.98
▼ $0.12 (-5.71%)
Day range
$1.97 – $2.10
Year range
$0.41 – $3.43
Open
$2.09
Previous close
$2.10
Market cap
$126.09M
Volume (24h)
$273.6K
Volume (52w)
$541.72K
Performance
7D
▼ -5.26%
1M
▼ -6.60%
3M
▼ -11.61%
6M
▲ 9.39%
1Y
▼ -20.48%
YTD
▲ 164.18%
3Y
▼ -44.23%
5Y
▼ -94.79%
All-time
▼ -99.94%
Key statistics
P/E ratio
-3.70
EPS (TTM)
$-0.54
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
63.7M
About TuHURA Biosciences
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1156.42 | 0.49% |
JNJ Johnson & Johnson |
$254.52 | -0.58% |
ABBV AbbVie |
$262.04 | 0.29% |
MRK Merck & Co. |
$139.70 | -2.76% |
UNH UnitedHealth Group Incorp… |
$371.61 | -0.19% |